Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hyperthermia × Dacarbazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 28 Hodgkin Disease 24 Lymphoma 8 Sarcoma 7 Uveal Melanoma 5 Neoplasm Metastasis 4 Neoplasms 2 Leiomyosarcoma 2 Solitary Fibrous Tumors 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Immunotherapy 1 Hyperthermia 1 HIV Infections 1 Carcinoma 1 Advanced Melanoma 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Complex 1

Interventions

Diathermy 5 Radiotherapy 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 tislelizumab 1 sodium thiosulfate 1 anlotinib 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Radiation 1 Laparotomy 1 Ifosfamide 1 Fluorouracil 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡